Format

Send to

Choose Destination
Allergy. 2018 Dec 28. doi: 10.1111/all.13714. [Epub ahead of print]

Determinants of omalizumab drug survival in a long-term daily practice cohort of patients with Chronic Urticaria.

Author information

1
Department of Dermatology, University Medical Center Utrecht, Utrecht, the Netherlands.
2
Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
PMID:
30593687
DOI:
10.1111/all.13714

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center